Aceclofenac 100mg + Paracetamol 325mg Tablets are a pharmaceutical combination formulation containing two active pharmaceutical ingredients in a standardized solid dosage form. Each tablet contains Aceclofenac 100mg and Paracetamol 325mg, formulated with suitable pharmaceutical excipients to achieve the desired physical and chemical characteristics.
Combination formulations require careful development because the active ingredients may have different physical properties and formulation requirements. The manufacturing process is designed to achieve appropriate uniformity and consistency throughout the finished product.
From raw-material selection to final packaging, every stage of pharmaceutical production contributes to the overall quality of the formulation. Controlled processing, appropriate testing, and documented manufacturing procedures help support consistent product characteristics from batch to batch.
The active ingredients in this formulation are Aceclofenac 100mg and Paracetamol 325mg. Both ingredients are incorporated into a single tablet according to their specified strengths.
During formulation development, pharmaceutical scientists evaluate different properties of the active ingredients, including particle size, flow characteristics, solubility, moisture sensitivity, compatibility, and stability. These factors can influence the selection of suitable excipients and manufacturing techniques.
Excipients may be included to support powder flow, blending, granulation, compression, tablet integrity, and other physical properties. The formulation is optimized to achieve appropriate content uniformity and consistent tablet characteristics.
The combination of two active pharmaceutical ingredients also requires suitable analytical methods for evaluating the individual components. Proper formulation development helps establish a reproducible manufacturing process that can be maintained during commercial production.
The manufacturing of Aceclofenac 100mg + Paracetamol 325mg Tablets begins with the procurement and quality assessment of pharmaceutical-grade raw materials. Materials that meet predefined specifications are approved for further processing.
Depending on the selected manufacturing technology, the production process may involve dispensing, sifting, blending, granulation, drying, lubrication, compression, dedusting, inspection, and packaging.
Controlled blending is particularly important for combination tablets because both active ingredients need to be distributed consistently throughout the formulation. Manufacturing parameters can be monitored during different stages to maintain process consistency.
Tablet compression is carried out using suitable equipment and controlled parameters. The resulting tablets may then undergo inspection to assess their physical appearance and identify any manufacturing defects.
A properly established manufacturing process helps maintain consistency in tablet weight, dimensions, hardness, and overall appearance across different production batches.
Quality testing is an essential part of pharmaceutical manufacturing. Aceclofenac 100mg + Paracetamol 325mg Tablets can undergo a range of physical and analytical evaluations according to established product specifications.
Physical parameters may include appearance, average weight, weight variation, thickness, hardness, friability, and disintegration. Analytical testing can be performed to determine the quantity and uniformity of the active pharmaceutical ingredients.
Because the formulation contains both Aceclofenac and Paracetamol, appropriate analytical procedures are important for evaluating each ingredient individually. Content uniformity testing can help assess whether the active ingredients are distributed consistently throughout the tablet batch.
Stability evaluation may also be performed under defined storage conditions. These studies can provide information regarding the physical and chemical characteristics of the formulation over the specified period.
Maintaining proper documentation of testing results, production parameters, and batch information provides traceability and supports an organized quality-management system.
The packaging of Aceclofenac 100mg + Paracetamol 325mg Tablets is designed to protect the finished tablets during storage, transportation, handling, and distribution. Appropriate packaging materials are selected according to product characteristics and applicable requirements.
Primary packaging provides a protective barrier for individual tablets, while secondary packaging can provide additional protection and facilitate product identification.
The product label generally contains important information such as the formulation name, composition, strength, batch number, manufacturing details, expiry information, manufacturer details, and other applicable regulatory information.
Packaging also provides an opportunity for pharmaceutical companies to establish a consistent brand identity. A coordinated design across different products can make a pharmaceutical portfolio more recognizable and professionally presented.
Clear product identification is particularly valuable when a company manages multiple formulations with different strengths and combinations.
Aceclofenac 100mg + Paracetamol 325mg Tablets can be incorporated into a broader pharmaceutical tablet portfolio. Combination formulations can complement other products and allow pharmaceutical businesses to maintain a diversified range.
For manufacturers, distributors, and pharmaceutical franchise businesses, product selection involves several considerations, including formulation quality, manufacturing capacity, packaging standards, documentation, supply consistency, and quality-control procedures.
Reliable production and organized supply-chain management are important for maintaining product availability across different markets. Manufacturers may use batch planning, inventory management, documented production schedules, and quality-release procedures to support a consistent supply.
A professionally managed product portfolio can also help pharmaceutical businesses build stronger relationships with distributors and business partners. Consistency in product quality and packaging contributes to a more organized overall brand presence.
The overall quality of Aceclofenac 100mg + Paracetamol 325mg Tablets depends on multiple stages of pharmaceutical development and manufacturing. Starting with suitable raw materials, the process continues through formulation design, controlled production, analytical testing, packaging, storage, and distribution.
Quality-focused manufacturing places emphasis on process control, equipment maintenance, documentation, testing procedures, and batch traceability. These practices help manufacturers maintain defined product specifications and improve consistency between production batches.
For a combination formulation containing Aceclofenac 100mg and Paracetamol 325mg, particular attention can be given to active-ingredient uniformity, assay, tablet characteristics, stability, packaging integrity, and manufacturing consistency.
A reliable pharmaceutical product is the result of coordinated efforts across formulation development, production, quality assurance, quality control, packaging, and supply-chain operations.
We combine quality, innovation, and strong distribution to help our partners grow successfully in the pharma market.
The company is offering business opportunity for scalable and sustainable returns to its associates. We are engaged in discovery, development and commercialization of pharmaceutical medicine keeping in mind its quality and affordability.
© Novolilly 2025. All Rights Reserved – Developed & Managed By Kavir Infotech